predicting recurrent c.diff infection with emr data 1203
14. Kollef MH, Chen Y, Heard K, et al. A randomized trial of real-time automated clinical deterioration alerts sent to a rapid response team. J Hosp Med 2014;9:424–429.
15. Escobar GJ, Dellinger RP. Early detection, prevention, and miti- gation of critical illness outside intensive care settings. J Hosp Med 2016;11:S5–S10.
16. Escobar GJ, Turk BJ, Ragins A, et al. Piloting electronic medical record-based early detection of inpatient deterioration in com- munity hospitals. J Hosp Med 2016;11:S18–S24.
17. Watt M, Dinh A, Le Monnier A, Tilleul P. Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France. J Med Econ 2017;20: 678–686.
18. Nelson RL, Suda KJ, Evans CT. Antibiotic treatment for Clostridium difficile–associated diarrhoea in adults. Cochrane Database Syst Rev 2017;3:CD004610.
19. Wilcox MH, Gerding DN, Poxton IR, et al. Bezlotoxumab for prevention of recurrent Clostridium difficile infection. N Eng. J Med 2017;376:305–317.
20. Escobar GJ, Greene JD, Gardner MN, Marelich GP, Quick B, Kipnis P. Intra-hospital transfers to a higher level of care: con- tribution to total hospital and intensive care unit (ICU) mortality and length of stay (LOS). J Hosp Med 2011;6:74–80.
21. Liu V, Kipnis P, Rizk NW, Escobar GJ. Adverse outcomes asso- ciated with delayed intensive care unit transfers in an integrated healthcare system. J Hosp Med 2012;7:224–230.
22. Escobar GJ, Gardner MN, Greene JD, Draper D, Kipnis P. Risk- adjusting hospital mortality using a comprehensive electronic record in an integrated health care delivery system. Med Care 2013;51:446–453.
23. Selby JV. Linking automated databases for research in managed care settings. Ann Intern Med 1997;127:719–724.
24. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–619.
25. Zilberberg MD, Reske K, Olsen M, Yan Y, Dubberke ER. Devel- opment and validation of a recurrent Clostridium difficile risk-prediction model. J Hosp Med 2014;9:418–423.
26. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile–associated disease in a setting of
endemicity: identification of novel risk factors. Clin Infect Dis 2007;45: 1543–1549.
27. Dubberke ER, Yan Y, Reske KA, et al. Development and valida- tion of a Clostridium difficile infection risk prediction model. Infect Control Hosp Epidemiol 2011;32:360–366.
28. Hastie T, Tibshirani R, Friedman JH. The Elements of Statistical Learning: Data Mining, Inference, and Prediction. 2nd ed. New York: Springer Verlag; 2009.
29. Allison PD. Logistic Regression Using SAS: Theory and Application. 2nd ed. Cary, NC: SAS Institute; 2012.
30. Hastie T, Tibshirani R, Friedman J, Franklin J. The elements of statistical learning: data mining, inference and prediction. Mathemat Intelligenc 2005;27:83–85.
31. Hosmer DW, Lemeshow S. Applied Survival Analysis: Regression Modelling of Time to Event Data. Hoboken, NJ: Wiley; 2008.
32. Cook DA, Duke G, Hart GK, Pilcher D, Mullany D. Review of the application of risk-adjusted charts to analyse mortality outcomes in critical care. Crit Care Resusc 2008;10:239–251.
33. Crowson CS, Atkinson EJ, Therneau TM. Assessing calibration of prognostic risk scores. Stat Method Med Res 2014;25:1692–1706.
34. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007;115:928–935.
35. Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157–172; discussion 207–212.
36. Estrella A, Mishkin FS. Predicting US recessions: financial vari- ables as leading indicators. Rev Econ Statist 1998;80:45–61.
37. McDonald EG, Milligan J, Frenette C, Lee TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile Infection. JAMA Intern Med 2015;175:784–791.
38. Deshpande A, Pasupuleti V, Thota P, et al. Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2015;36:452–460.
39. Kuntz JL, Johnson ES, Raebel MA, et al. Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk score. Clin Microbiol Infect 2015;21:256–262.
40. Kuntz JL, Smith DH, Petrik AF, et al. Predicting the risk of Clos- tridiumdifficile infection upon admission: a score to identify patients for antimicrobial stewardship efforts. Perm J 2016;20:20–25.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144
